Linden Advisors’s Warburg Pincus Capital Corporation I-B Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 WPCB.WS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-250,000
Closed -$16K 688
2022
Q3
$16K Hold
250,000
﹤0.01% 611
2022
Q2
$67K Hold
250,000
﹤0.01% 550
2022
Q1
$118K Buy
+250,000
New +$182K ﹤0.01% 573

Other funds holding WPCB.WS

Linden Advisors's WPCB.WS Position: Q4 2022 in Review

Linden Advisors sold out of Warburg Pincus Capital Corporation I-B Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 (WPCB.WS) in Q4 2022, closing a stake of 250,000 shares — an estimated $16K sold.

Linden Advisors first reported a position in WPCB.WS in Q1 2022 and held it in 3 quarters. The position peaked at $118K in Q1 2022. 9 funds tracked by Wall St. Rank hold WPCB.WS as of Q4 2022.

  • Linden Advisors reported no remaining Warburg Pincus Capital Corporation I-B Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 position as of Q4 2022 after selling out during the quarter.
  • Linden Advisors sold 250,000 Warburg Pincus Capital Corporation I-B Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 shares in Q4 2022, an estimated $16K.
  • Linden Advisors first reported a position in Warburg Pincus Capital Corporation I-B Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 in Q1 2022 and held it in 3 quarters.
  • Linden Advisors's Warburg Pincus Capital Corporation I-B Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 position peaked at $118K in Q1 2022.
  • 9 funds tracked by Wall St. Rank held Warburg Pincus Capital Corporation I-B Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 as of Q4 2022.

Based on Linden Advisors's 13F filing for Q4 2022, filed 14 Feb 2023.